Akèy › Degeneresans Makilè Mouye
Etid klinik pou Degeneresans Makilè Mouye ap rekrite nan Etazini
6 etid pou Degeneresans Makilè Mouye ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Hagerstown, MD4 etid
- Sacramento, CA3 etid
- Eugene, OR3 etid
- Nashville, TN3 etid
- Tampa, FL3 etid
- Columbia, SC3 etid
- Carmel, IN3 etid
- Austin, TX3 etid
- Orlando, FL3 etid
- Fort Worth, TX3 etid
Pa eta
- Arizona4 etid
- Colorado3 etid
- Florid5 etid
- Illinois4 etid
- Indiana3 etid
- Kalifòni4 etid
- Maryland4 etid
- Massachusetts3 etid
- New Jersey3 etid
- New York3 etid
- North Carolina3 etid
- Oregon4 etid
- Pennsylvania4 etid
- South Carolina4 etid
- Tennessee4 etid
- Texas4 etid
- Utah3 etid
- Virginia3 etid
- Washington3 etid
- Wisconsin3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Ap rekriteFaz 2/3
Laj 50 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT074402254D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Ap rekriteFaz 1/2
Laj 50 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Ap rekriteFaz 2/3
Laj 50 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07496567Stem Cell Ophthalmology Treatment Study II
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT03011541Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT07064759MMP-9 Inhibition for Recalcitrant Wet AMD
Ap rekriteFaz 2
Laj 50 a 99 · Tout sèks · Mizajou Apr 2, 2026 · NCT04504123Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.